Acylated Ghrelin as a Multi-Targeted Therapy for Alzheimer’s and Parkinson’s Disease.

Acylated Ghrelin as a Multi-Targeted Therapy for Alzheimer’s and Parkinson’s Disease.
Related ArticlesAcylated Ghrelin as a Multi-Targeted Therapy for Alzheimer's and Parkinson's Disease. Front Neurosci. 2020;14:614828 Authors: Reich N, Hölscher C Abstract Much thought has been given to the impact of Amyloid Beta, Tau and Alpha-Synuclein in the development of Alzheimer's disease (AD) and Parkinson's disease (PD), yet the clinical failures of the recent decades indicate that there are further pathological ... read more
Source: PubMedPublished on 2021-01-01